Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Comparison of the AccuPower HIV-1 Quant Kit and Aptima HIV-1 Quant Dx Assay for quantification of HIV-1 plasma viral load.

PMID: 41966529 · 2026

JournalDiagnostic microbiology and infectious disease
Year2026
PMID41966529

Abstract

HIV-1 viral load testing is essential for monitoring antiretroviral therapy response in HIV-1-infected patients. This study aimed to evaluate the clinical performance of the AccuPower HIV-1 Quant Kit (Bioneer), a newly developed HIV-1 viral load assay designed for use on the fully automated ExiStation FA 96 system. A total of 376 archived plasma samples were tested in parallel using the AccuPower HIV-1 assay and the Aptima HIV-1 Quant Dx Assay (Hologic), an FDA-cleared HIV-1 viral load assay per

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.